Literature DB >> 27920816

Concomitant extraspinal hyperostosis and osteoporosis in a patient with congenital ichthyosis.

Niloufar Torkamani1, Pramit Phal2, Ravi Savarirayan3, Peter Simm4, George Varigos1, John Wark1.   

Abstract

Ichthyosiform dermatosis is a term referred to a group of disorders that have as their basis a disorder of keratinization (1). These conditions which are present at birth result in a generalized dry, scaly skin without any inflammation. There are several types of ichthyosis based on their clinical presentation and mode of inheritance. The most common types are: ichthyosis vulgaris, X-linked recessive ichthyosis, epidermolytic hyperkeratosis (bullous), lamellar ichthyosis and non-bullous ichthyosiform erythroderma. Lamellar ichthyosis, which is inherited in an autosomal recessive pattern, shows genetic heterogeneity with the most severe type being due to mutations in the transglutaminase-1 gene. This condition presents with skin changes at birth and cases are referred to as collodion babies. Initially, the stratum corneum is smooth and appears as though it is covered with cellophane. This layer is discarded a few days after birth, leaving a generalized inflamed and scaly appearance. The skin is tight at this stage and may cause ectropion, and difficulties in feeding and temperature regulation. Lamellar ichthyosis is characterized by plate-like scales that last for life and can significantly impact the patient's quality of life (2). We report here a case of multiple extraspinal hyperostoses concomitant with marked osteoporosis and vitamin D deficiency in a patient taking acitretin for 20 years due to severe congenital lamellar ichthyosis.

Entities:  

Keywords:  extraspinal hyperostosis; lamellar ichthyosis; osteoporosis; retinoids

Year:  2016        PMID: 27920816      PMCID: PMC5119717          DOI: 10.11138/ccmbm/2016.13.2.157

Source DB:  PubMed          Journal:  Clin Cases Miner Bone Metab        ISSN: 1724-8914


  18 in total

1.  Acitretin-induced enthesitis in a patient with psoriatic arthritis.

Authors:  Véronique Vincent; Laurent Zabraniecki; Olivier Loustau; Bertrand Godfrin; Frédérique Bertrand Latour; Jean-Jacques Railhac; Bernard Fournié
Journal:  Joint Bone Spine       Date:  2005-07       Impact factor: 4.929

2.  Acitretin-related ossification.

Authors:  Maarten J Rood; Sjan P M Lavrijsen; Tom W J Huizinga
Journal:  J Rheumatol       Date:  2007-04       Impact factor: 4.666

3.  Retinoic acid regulates growth hormone gene expression.

Authors:  G Bedo; P Santisteban; A Aranda
Journal:  Nature       Date:  1989-05-18       Impact factor: 49.962

4.  Extraspinal enthesopathy caused by isotretinoin therapy.

Authors:  J R Brandt; T J Mick
Journal:  J Manipulative Physiol Ther       Date:  1999 Jul-Aug       Impact factor: 1.437

Review 5.  Uses and complications of isotretinoin therapy.

Authors:  C N Ellis; K J Krach
Journal:  J Am Acad Dermatol       Date:  2001-11       Impact factor: 11.527

6.  Association between long-term acitretin therapy and osteoporosis: no evidence of increased risk.

Authors:  E A McMullen; P McCarron; A D Irvine; O M Dolan; G E Allen; D Irvine
Journal:  Clin Exp Dermatol       Date:  2003-05       Impact factor: 3.470

7.  Acromegalic axial arthropathy: a clinical case-control study.

Authors:  Raffaele Scarpa; Davide De Brasi; Rosario Pivonello; Paolo Marzullo; Francesco Manguso; Antonio Sodano; Pasquale Oriente; Gaetano Lombardi; Annamaria Colao
Journal:  J Clin Endocrinol Metab       Date:  2004-02       Impact factor: 5.958

8.  Bone mineral density of the lumbar spine in psoriatic patients with long term etretinate therapy.

Authors:  N Okada; M Nomura; S Morimoto; T Ogihara; K Yoshikawa
Journal:  J Dermatol       Date:  1994-05       Impact factor: 4.005

Review 9.  Congenital ichthyosis: an overview of current and emerging therapies.

Authors:  Anders Vahlquist; Agneta Gånemo; Marie Virtanen
Journal:  Acta Derm Venereol       Date:  2008       Impact factor: 4.437

10.  Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor-γ agonists.

Authors:  Kengo Shimono; Wei-En Tung; Christine Macolino; Amber Hsu-Tsai Chi; Johanna H Didizian; Christina Mundy; Roshantha A Chandraratna; Yuji Mishina; Motomi Enomoto-Iwamoto; Maurizio Pacifici; Masahiro Iwamoto
Journal:  Nat Med       Date:  2011-04-03       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.